Preliminary Results of Phase II Trial of Brentuximab Vedotin and Lenalidomide in Relapsed / Refractory Cutaneous / Peripheral T-Cell Lymphomas

17 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login